NEW YORK, December 31, 2025, 1:03 ET — Regular session.
UnitedHealth Group Incorporated shares fell 0.4% to $330.86 on Wednesday, extending a muted year-end session as investors weighed fresh legal developments tied to the ALPHV “BlackCat” ransomware gang. The stock traded between $330.32 and $333.24.
The timing matters for UnitedHealth, which is heading into 2026 with investors focused on whether the insurer can keep a lid on costs while it works through a stack of operational and regulatory issues.
That scrutiny tends to show up in the group’s pricing power and its medical care ratio — the share of premium revenue that gets spent on patient care — a key driver of insurance margins.
Late Tuesday, the U.S. Justice Department said two cybersecurity professionals pleaded guilty to conspiring to extort American targets while working with ALPHV BlackCat, Reuters reported. Reuters said it could not determine the identity or status of a third alleged co-conspirator, and said the gang disappeared last year after a sweeping cyberattack at UnitedHealth Group.
Wall Street trading was subdued on the last trading day of 2025, with investors digesting minutes from the Federal Reserve’s December meeting that underscored divisions among policymakers over the path for U.S. interest rates.
Other managed-care names were mixed. Humana dipped about 0.1%, Cigna was little changed and Elevance Health rose about 0.6%, while CVS Health slipped about 0.5%.
UnitedHealth’s sprawling Optum business has been a central point for investors trying to gauge how the company balances care delivery, pharmacy services and insurance underwriting — and what that mix means for margins and compliance risk.
On Dec. 19, UnitedHealth said external audits of its health services and pharmacy benefit units would lead to operational changes, including more automation and increased standardization of internal processes, Reuters reported. “The work is already well underway,” CEO Stephen Hemsley said in a stakeholder letter that outlined 23 action plans; Reuters also reported that one focal point was HouseCalls, an in-home health assessment program that submits diagnoses used to help determine Medicare Advantage payments, and that the company said it was cooperating with Justice Department investigations into Medicare Advantage billing practices.
For equity investors, the concern is straightforward: if care use rises faster than pricing assumptions, or if compliance-related costs climb, earnings can get squeezed quickly in a business built on thin percentage margins.
The next hard catalyst is late January. UnitedHealth said it will release full-year 2025 financial results and provide 2026 financial guidance on Tuesday, Jan. 27, before the market opens, and host a teleconference at 8:00 a.m. ET.
Until then, traders are likely to keep reacting to headline risk — from cybersecurity to policy and oversight — while looking for signals that the company’s cost trend is stabilizing ahead of the 2026 outlook.
